Mingdong Huang mainly focuses on Biochemistry, Cell biology, Lanthanide, Nanotechnology and Plasma protein binding. He focuses mostly in the field of Biochemistry, narrowing it down to topics relating to Urokinase and, in certain cases, Vitronectin. His Vitronectin research is multidisciplinary, incorporating elements of Plasminogen activator and Fibrinolysis.
His Cell biology research incorporates themes from Immunology, Receptor, Major histocompatibility complex and T-cell receptor. His Nanotechnology study incorporates themes from Doping, Singlet oxygen, Ligand, Photodynamic therapy and Avidin. His research in Plasma protein binding intersects with topics in Protein structure, Monosaccharide, Human serum albumin and Binding site.
His primary areas of study are Biochemistry, Plasminogen activator, Urokinase receptor, Stereochemistry and Photodynamic therapy. His study in Proteases, Serine protease, Binding site, Protein structure and Peptide is carried out as part of his studies in Biochemistry. His research on Plasminogen activator also deals with topics like
His Urokinase receptor research is multidisciplinary, incorporating perspectives in Biophysics, Vitronectin and Cell biology. The study incorporates disciplines such as Antibody and Crystal structure in addition to Stereochemistry. His biological study spans a wide range of topics, including Cancer, Cancer research, In vivo and Photosensitizer.
His scientific interests lie mostly in Plasminogen activator, Cancer research, Cancer, In vivo and Photodynamic therapy. His study in Plasminogen activator focuses on Urokinase receptor in particular. His Urokinase receptor research includes themes of Ligand, Snake venom, Stereochemistry, Cell surface receptor and Binding site.
His Cancer research study combines topics in areas such as Matriptase, Metastasis and Drug delivery. The Photodynamic therapy study combines topics in areas such as Antitumor therapy, Phthalocyanine, Reactive oxygen species, Photosensitizer and Combination therapy. His research on Serine protease concerns the broader Biochemistry.
Mingdong Huang spends much of his time researching Plasminogen activator, Cancer research, Cancer, Serine protease and Photodynamic therapy. His work carried out in the field of Plasminogen activator brings together such families of science as Fibrinolysis, Antigen, Chromatography and Urokinase. His Urokinase research integrates issues from Proteases, Serine and Diuretic.
His Cancer research research is multidisciplinary, relying on both Human serum albumin, Urokinase receptor, Metastasis, Activator and Cytotoxicity. His study focuses on the intersection of Serine protease and fields such as Pharmacology with connections in the field of Drug resistance and In vivo. He combines subjects such as Drug carrier, Drug delivery, Combination therapy and Photosensitizer with his study of Photodynamic therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: